MARKET

LUNG

LUNG

Pulmonx Corp
NASDAQ
1.505
+0.085
+5.99%
After Hours: 1.508 +0.003 +0.22% 19:31 02/20 EST
OPEN
1.430
PREV CLOSE
1.420
HIGH
1.510
LOW
1.415
VOLUME
270.18K
TURNOVER
--
52 WEEK HIGH
9.37
52 WEEK LOW
1.310
MARKET CAP
62.08M
P/E (TTM)
-1.0669
1D
5D
1M
3M
1Y
5Y
1D
Pulmonx Is Maintained at Buy by D. Boral Capital
Dow Jones · 1d ago
Pulmonx Price Target Maintained With a $14.00/Share by D. Boral Capital
Dow Jones · 1d ago
D. Boral Capital Maintains Buy on Pulmonx, Maintains $14 Price Target
Benzinga · 1d ago
Pulmonx Corporation published an update to their financial calendar
Reuters · 1d ago
Weekly Report: what happened at LUNG last week (0209-0213)?
Weekly Report · 5d ago
Pulmonx Corporation (NASDAQ:LUNG) Not Doing Enough For Some Investors As Its Shares Slump 29%
Simply Wall St · 02/11 18:52
Weekly Report: what happened at LUNG last week (0202-0206)?
Weekly Report · 02/09 10:30
Weekly Report: what happened at LUNG last week (0126-0130)?
Weekly Report · 02/02 10:30
More
About LUNG
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides minimally invasive treatments for chronic obstructive pulmonary disease (COPD). The Company’s Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, LungTraX Platform, and StratX Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD. The LungTraX Platform is a cloud-based quantitative CT (QCT) analysis service that provides physicians with multiple products, LungTraX Connect, to improve workup efficiency, LungTraX Detect, to enable patient identification and an easy-to-read StratX Lung report that it designed for its solution that includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a proprietary balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation.

Webull offers Pulmonx Corp stock information, including NASDAQ: LUNG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUNG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUNG stock methods without spending real money on the virtual paper trading platform.